BIIB34.SA

Biogen Inc · Healthcare · Drug Manufacturers - General

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$30.35B

PE Ratio

110.34

EV to Ebitda

—

Earnings Yield

1.00%

Revenue (TTM)

$2.00B

Net Income (TTM)

$275.6M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

2.00%

Profit Margin

14.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core5 fields›

Market Cap$30.35B

Revenue TTM$2.00B

Shares Outstanding889.4M

Insider Ownership0.00%

Institutional Ownership0.00%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)2.00%

Rev Growth Est 1Y Forward0.03

EPS Growth (Quarterly YoY)31.00%

EPS Growth Est Quarterly0

CFO Growth (Quarterly YoY)149.00%

FCF Growth (Quarterly YoY)164.00%

Operations21 fields›

Revenue TTM$2.00B

Gross Margin TTM79.00%

Gross Margin (Quarterly)73.00%

Operating Margin TTM23.00%

Operating Margin (Quarterly)19.00%

Operating Expenses TTM$60.2M

Profit Margin TTM14.00%

Profit Margin (Quarterly)13.00%

Net Income TTM$275.6M

EPS TTM7.61

EPS (Quarterly)0.36

EBIT Margin TTM34.92%

EBITDA Margin TTM35.00%

EBITDA TTM$706.2M

CFO % of Revenue TTM50.00%

CFO % of Revenue (Quarterly)26.00%

CFO TTM$996.9M

Capex % of Revenue TTM5.00%

Capital Expenditures$94.5M

FCF % of Revenue (Quarterly)20.00%

FCF TTM$465.3M

Efficiency1 fields›

ROA6.00%

Valuation11 fields›

P/E (TTM)110.34

P/E Forward13.46

PEG3.91

P/CFO30.5

P/FCF65.35

EV/Revenues (TTM)3.04

Price To Book8.12

Price to Tangible Book48.68

Earnings Yield1.00%

FCF Yield2.00%

Payout Ratio0.00%

Liquidity8 fields›

Cash Per Share25.99

Current Ratio2.68

Goodwill & Intangibles$15542.20T

Total Assets$5.92B

Total Liabilities$8.78B

Shareholders Equity$3.75B

Interest Expense$60.2M

Goodwill % of Assets52715624.00%

Yields3 fields›

Payout Ratio0.00%

Earnings Yield1.00%

Buyback Yield1.00%